Charles A. O'Brien
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Charles A. O'Brien has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Song-Chang Lin
Division of Endocrinology & Metabolism, Department of Medicine, Center for Osteoporosis & Metabolic Bone Diseases, and the McClellan VAMC, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
2 shared publicationsStavros C. Manolagas
Division of Endocrinology & Metabolism, Department of Medicine, Center for Osteoporosis & Metabolic Bone Diseases, and the McClellan VAMC, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
2 shared publicationsIgor Gubrij
From the Divisions of ‡Endocrinology and Metabolism and ‖Pediatric Hematology/Oncology, Departments of Medicine and Pediatrics, Center for Osteoporosis and Metabolic Bone Diseases, and the Central Arkansas Healthcare System, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
1 shared publicationRobert L. Saylors
From the Divisions of ‡Endocrinology and Metabolism and ‖Pediatric Hematology/Oncology, Departments of Medicine and Pediatrics, Center for Osteoporosis and Metabolic Bone Diseases, and the Central Arkansas Healthcare System, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
1 shared publicationTeresita Bellido
Division of Endocrinology & Metabolism, Department of Medicine, Center for Osteoporosis & Metabolic Bone Diseases, and the McClellan VAMC, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
1 shared publication
Latest Publications
- 14 September 2000
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 79 (4) , 532-541
Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines
- 14 September 2000
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 79 (4) , 532-541
Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines
- Open Access
- 1 July 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (27) , 19301-19308
STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone
- 1 July 1999
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (27) , 19301-19308
Open AccessSTAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone